

Estée Lauder Companies vs Constellation Brands
Global luxury beauty company selling makeup and skincare vs Major North American producer of premium alcoholic beverages. Which is the better buy for your portfolio in May 2026? Plain-English answer below.
Estee Lauder built its empire on prestige beauty brands sold through department stores and travel retail, while Constellation Brands distributes premium beer, wine, and spirits through U.S. wholesale channels, putting two consumer companies with pricing power in front of very different post-pandemic demand dynamics. Both rely on brand investment and channel relationships to sustain premium price points. Estee Lauder Companies vs Constellation Brands tracks revenue recovery, channel mix shifts, and which management team is more effectively navigating its sector's unique headwinds.
Estee Lauder built its empire on prestige beauty brands sold through department stores and travel retail, while Constellation Brands distributes premium beer, wine, and spirits through U.S. wholesale ...
Why It's Moving

Estée Lauder’s analyst backdrop stays cautiously constructive as Wall Street looks for a rebound.
- Analyst targets remain scattered, but the center of gravity still points to upside, suggesting Wall Street expects a gradual recovery rather than a rapid rerating.
- The split between Buy and Hold ratings shows conviction is improving, but not uniformly, which keeps the stock sensitive to any new earnings surprise or guidance update.
- With no major company catalyst in the last week, the broader tone is being set by consumer-staples sector rotation and confidence in premium beauty demand rather than a single headline event.

STZ is drawing steady analyst support as investors weigh softer recent trading against a still-positive 2026 outlook.
- Analyst sentiment is still net positive, with most coverage clustered around Buy or Overweight ratings, which is helping support the stock despite near-term uncertainty.
- Consensus price targets remain above the current share price, signaling that analysts still see room for recovery if operating trends stabilize.
- With no major company-specific catalyst in the last seven days, investors are likely focusing on broader beverage and consumer spending trends, along with upcoming earnings expectations.

Estée Lauder’s analyst backdrop stays cautiously constructive as Wall Street looks for a rebound.
- Analyst targets remain scattered, but the center of gravity still points to upside, suggesting Wall Street expects a gradual recovery rather than a rapid rerating.
- The split between Buy and Hold ratings shows conviction is improving, but not uniformly, which keeps the stock sensitive to any new earnings surprise or guidance update.
- With no major company catalyst in the last week, the broader tone is being set by consumer-staples sector rotation and confidence in premium beauty demand rather than a single headline event.

STZ is drawing steady analyst support as investors weigh softer recent trading against a still-positive 2026 outlook.
- Analyst sentiment is still net positive, with most coverage clustered around Buy or Overweight ratings, which is helping support the stock despite near-term uncertainty.
- Consensus price targets remain above the current share price, signaling that analysts still see room for recovery if operating trends stabilize.
- With no major company-specific catalyst in the last seven days, investors are likely focusing on broader beverage and consumer spending trends, along with upcoming earnings expectations.
Investment Analysis
Pros
- Estée Lauder reported Q4 EPS above expectations, showing resilience in a challenging prestige beauty market.
- The company expanded gross margins by 230 basis points, reflecting improved cost management and operational efficiency.
- China sales are stabilising with signs of market share gains, offering potential for future revenue recovery.
Considerations
- Organic sales declined by 8% for the full fiscal year, indicating persistent demand headwinds in key markets.
- Operating margin contracted by 220 basis points, highlighting ongoing profitability pressures despite margin improvements.
- Stock price remains volatile, with recent declines despite earnings beats, reflecting investor concerns over growth prospects.
Pros
- Constellation Brands benefits from exclusive US rights to high-growth Mexican beer brands like Corona and Modelo.
- The company operates with best-of-breed margins and is well-positioned to capitalise on strong secular beverage trends.
- Shares trade at a notable discount to fair value estimates, suggesting potential upside for value-oriented investors.
Considerations
- Recent quarterly EPS declined by 16%, reflecting short-term profitability challenges in the beverage segment.
- The business faces evolving industry dynamics, including shifting consumer preferences and competitive pressures.
- Exposure to regulatory and macroeconomic risks in the alcohol sector could impact future growth and margins.
Estée Lauder Companies (EL) Next Earnings Date
The next earnings date for EL is expected on August 19, 2026, before the market opens. This report should cover fiscal Q4 2026. Estée Lauder last reported results on May 1, 2026, and the next release follows its usual late-summer earnings pattern.
Constellation Brands (STZ) Next Earnings Date
The next earnings date for STZ is estimated for Tuesday, July 7, 2026. It is expected to cover fiscal Q4 2026 results for Constellation Brands. The company has not formally confirmed the date yet, but this timing matches the typical late-June to early-July reporting pattern.
Estée Lauder Companies (EL) Next Earnings Date
The next earnings date for EL is expected on August 19, 2026, before the market opens. This report should cover fiscal Q4 2026. Estée Lauder last reported results on May 1, 2026, and the next release follows its usual late-summer earnings pattern.
Constellation Brands (STZ) Next Earnings Date
The next earnings date for STZ is estimated for Tuesday, July 7, 2026. It is expected to cover fiscal Q4 2026 results for Constellation Brands. The company has not formally confirmed the date yet, but this timing matches the typical late-June to early-July reporting pattern.
Buy EL or STZ in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


